Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 39 results for "orchid chemicals and pharmaceuticals ltd"

Orchid Pharma received US FDA approval for two drugs

Email this Print Chennai-based Orchid Chemicals and Pharmaceuticals Ltd (OCPL) has received US Food and Drug Administartion's approval for its generic form of dementia drug Rivastigmine Capsules and hypertension drug Felodipine extended release ... Smart Investor, 1 month ago

Orchid Chemicals geta USFDA approval for Gemifloxacin Mesylate tablets

Orchid Chemicals Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity.
 Money Control1 month ago Orchid Chemicals & Pharmaceuticals Ltd receives US FDA approval with exclusivity  Equity Bulls1 month ago Orchid Chemicals net loss up by 83% in Q4  PharmaBiz1 month ago

Sensex up nearly 200 pts after buoyant start; Orchid Chemicals soars 12%

Stocks opened on a buoyant note on the Indian bourses this morning and the BSE benchmark Sensex sailed past the 27,000 mark in a flash, as investors indulged in some hectic buying at several counters, tracking positive global cues. Reacting ...
 Sify1 month ago Sensex rallies over 150 points on dovish signals from US Fed  Economic Times1 month ago Sensex ends day up 161 pts, Nifty above 8,000  Economic Times1 month ago Sensex up over 150 points, Nifty crosses 8,000; Sun TV surges 10%  Economic Times1 month ago

Several pharma cos with sharp drop in sales & profits in 5 years dampen investor's mood

Investments in shares of pharmaceutical companies is considered to be relatively safe as compared to other industry segments in the country, but in recent years that scenario has changed dramatically. Scrips of quite a few pharma companies are ...
 PharmaBiz1 week ago

Opening Bell | Global equities mixed, pharma stocks in focus

A file photo of the BSE building in Mumbai. Photo: Mint US markets closed marginally higher. S&P 500 gained 0.2% to 2,100 after the Federal Reserve said the US economy is likely strong enough to withstand an interest rate hike, reports Reuters .
 Livemint.com1 month ago

Lehman Brothers afterlife in India

Two Lehman Brothers funds—LB Mauritius III Ltd and LB Mauritius IV Ltd—collectively hold 6.24% in KSK Energy Ventures Ltd. Photo: Bloomberg Mumbai: More than seven years after it went belly up in the US, Wall Street's former blue chip Lehman ...
 Livemint.com1 month ago Lehman Brothers' afterlife in India  MSN News US1 month ago

Asthma Treatment Market - Global Size, Share, Trends, Segments Analysis and Industry Forecast to 2014-2020

Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Asthma Treatment Market: Global Industry Analysis and Forecast to 2020". This press release was orginally distributed by ReleaseWire New York, NY -- (ReleaseWire) -- ...
 Digital Journal1 month ago

Hospira Upgraded to Buy at Zacks (HSP)

Zacks upgraded shares of Hospira (NYSE:HSP) from a hold rating to a buy rating in a research note released on Friday morning, MarketBeat.Com reports. Zacks currently has $100.00 target price on the stock. According to Zacks, Hospira's ...
 WKRB News5 hours ago

Hospira Reaches New 1-Year High on Better-Than-Expected Earnings (HSP)

Hospira (NYSE:HSP) shares hit a new 52-week high on Thursday after the company announced better than expected quarterly earnings, Market Beat reports. The company traded as high as $89.45 and last traded at $89.44, with a volume of 286,793 shares ...
 SleekMoney1 day ago Hospira Hits New 52-Week High Following Better-Than-Expected Earnings (HSP)  WKRB News1 day ago Hospira (HSP) Announces Earnings Results  WKRB News3 days ago

Equities Research Analysts Upgrades for July, 14th (BIIB, BNKXF, HTGC, MDSO, MDXG, MHLD, MHO, MIND, MITEY, MLNX)

Equities Research Analysts upgrades for Tuesday, July 14th: Biogen Idec (NASDAQ:BIIB) was upgraded by analysts at Bank of America from a neutral rating to a buy rating. They currently have $466.00 price target on the stock. Bankia Sa ...
 SleekMoney2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less